Table 2:

Measurements of perfusion values determined with CASL and T2DSC

Patient No.	CASL Perfusion			T2DSC Perfusion
Patient No.	Tumor CBF (mL/min/100 g)	Tumor (% Si)	Total CBF (mL/min/100 g)	Tumor CBV (mL/100 g)	Tumor CBF (mL/min/100 g)	Tumor MTT (s)	Total CBF (mL/min/100 g)
1	91	1.33	26	ND	ND	ND	ND
2	180	4.05	33	67	342	12	55
3	110	1.07	38	22	205	7	76
4	72	0.97	41	4	44	6	49
5	197	1.79	63	59	356	10	81
6	59	0.55	47	13	135	6	76
7	191	2.83	50	68	279	15	70
8	116	1.23	49	33	177	11	71
9	48	0.57	45	ND	ND	ND	ND
10	65	0.70	31	4	59	4	61
11	43	0.44	35	9	63	9	51
12	77	0.68	27	41	258	10	93
13	56	0.66	23	22	126	12	64
14	23	0.28	41	5	178	5	73
15	87	0.71	65	23	54	8	104
16	101	0.72	34	16	190	5	68
17	102	0.75	31	32	183	11	90
18	114	0.47	51	23	127	11	63
19	46	0.41	16	21	157	8	83
20	74	0.56	28	21	153	9	73
21	38	0.36	44	15	76	12	74

Note:—T2DSC indicates T2-dynamic susceptibility contrast; CASL, continuous arterial spin labeling; %SI, percentage signal change relative to local signal intensity; CBF, cerebral blood flow; CBV, cerebral blood volume; MTT, mean transit time.